| Relationship between vancomycin trough concentrations and nephrotoxicity: a prospective multicenter trial JA Bosso, J Nappi, C Rudisill, M Wellein, PB Bookstaver, J Swindler, ... Antimicrobial agents and chemotherapy 55 (12), 5475-5479, 2011 | 299 | 2011 |
| American College of Clinical Pharmacy's vision of the future: postgraduate pharmacy residency training as a prerequisite for direct patient care practice JE Murphy, JM Nappi, JA Bosso, JJ Saseen, BA Hemstreet, MA Halloran, ... Pharmacotherapy 26 (5), 722-733, 2006 | 275 | 2006 |
| Individualization of phenytoin dosage regimens TM Ludden, JP Allen, WA Valutsky, AV Vicuna, JM Nappi, SF Hoffman, ... Clinical Pharmacology & Therapeutics 21 (3), 287-293, 1977 | 141 | 1977 |
| Continuous versus intermittent infusion of furosemide in acute decompensated heart failure MR Thomson, JM Nappi, SP Dunn, IB Hollis, JE Rodgers, AB Van Bakel Journal of cardiac failure 16 (3), 188-193, 2010 | 132 | 2010 |
| Evaluation of treatment with direct thrombin inhibitors in patients with heparin‐induced thrombocytopenia CH Dang, VL Durkalski, JM Nappi Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 26 (4 …, 2006 | 110 | 2006 |
| Rhabdomyolysis with concurrent atorvastatin and diltiazem JJ Lewin III, JM Nappi, MH Taylor Annals of Pharmacotherapy 36 (10), 1546-1549, 2002 | 92 | 2002 |
| Bosentan for the treatment of pulmonary arterial hypertension KW Kenyon, JM Nappi Annals of Pharmacotherapy 37 (7-8), 1055-1062, 2003 | 82 | 2003 |
| New recommendations from the 1999 American College of Cardiology/American Heart Association acute myocardial infarction guidelines SA Spinler, DE Hilleman, JWM Cheng, PA Howard, VF Mauro, LM Lopez, ... Annals of Pharmacotherapy 35 (5), 589-617, 2001 | 74 | 2001 |
| Aldosterone and aldosterone receptor antagonists in patients with chronic heart failure JM Nappi, A Sieg Vascular health and risk management, 353-363, 2011 | 66 | 2011 |
| Myocardial infarction in women: a critical appraisal of gender differences in outcomes DM Bell, J Nappi Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 20 (9 …, 2000 | 64 | 2000 |
| Warfarin and phenytoin interaction JM NAPPI Annals of internal medicine 90 (5), 852-852, 1979 | 52 | 1979 |
| The cardiovascular effects of eplerenone, a selective aldosterone-receptor antagonist KL Davis, JM Nappi Clinical therapeutics 25 (11), 2647-2668, 2003 | 51 | 2003 |
| Review of a new gastrointestinal drug—metoclopramide CD Ponte, JM Nappi American Journal of Hospital Pharmacy 38 (6), 829-833, 1981 | 49 | 1981 |
| Possible pharmacokinetic interaction with quinidine: ciprofloxacin or metronidazole? CE Cooke, GE Sklar, JM Nappi Annals of Pharmacotherapy 30 (4), 364-366, 1996 | 46 | 1996 |
| Improved exercise tolerance after administration of carnitine P Kosolcharoen, J Nappi, P Peduzzi, A Shug, A PATEL, T Filipek | 45 | 1981 |
| Mesalamine-associated hypersensitivity myocarditis in ulcerative colitis S Stelts, MH Taylor, J Nappi, AB Van Bakel Annals of Pharmacotherapy 42 (6), 904-905, 2008 | 40 | 2008 |
| Efficacy of intravenous pirmenol hydrochloride for treatment of ventricular arrhythmias: a controlled comparison with lidocaine JL Anderson, JR Lutz, SW Sanders, JM Nappi Journal of Cardiovascular Pharmacology 5 (2), 213-220, 1983 | 40 | 1983 |
| Type 2 diabetes mellitus and heart failure CK Choy, JE Rodgers, JM Nappi, ST Haines Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 28 (2 …, 2008 | 39 | 2008 |
| Barriers to clopidogrel adherence following placement of drug-eluting stents MJ Pallares, ER Powers, PL Zwerner, A Fowler, R Reeves, JM Nappi Annals of Pharmacotherapy 43 (2), 259-267, 2009 | 38 | 2009 |
| Multi-institutional study of women and underrepresented minority faculty members in academic pharmacy MA Chisholm-Burns, CA Spivey, D Billheimer, LS Schlesselman, ... American Journal of Pharmaceutical Education 76 (1), 7, 2012 | 37 | 2012 |
